Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.6280
-0.0020 (-0.32%)
Sep 4, 2026, 12:00 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 84.13 million as of September 3, 2026. Its market cap has decreased by -84.62% in one year.
Market Cap
84.13M
Enterprise Value
46.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 84.13M, a decrease of -85.04%. That is a compound annual growth rate of -22.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 84.13M | -79.37% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 137.52M |
| Active Biotech AB | 133.65M |
| Simris Group AB (PUBL) | 133.36M |
| Biovica International AB | 125.52M |
| Nanologica AB | 118.03M |
| Annexin Pharmaceuticals AB | 95.65M |
| Spago Nanomedical AB | 88.22M |
| Modus Therapeutics Holding AB | 69.74M |